171 related articles for article (PubMed ID: 19621241)
1. The distribution of lesions in 1-14-mm invasive breast carcinomas and its relation to metastatic potential.
Tot T; Pekár G; Hofmeyer S; Sollie T; Gere M; Tarján M
Virchows Arch; 2009 Aug; 455(2):109-15. PubMed ID: 19621241
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
Tot T
Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
[TBL] [Abstract][Full Text] [Related]
3. The metastatic capacity of multifocal breast carcinomas: extensive tumors versus tumors of limited extent.
Tot T
Hum Pathol; 2009 Feb; 40(2):199-205. PubMed ID: 18799193
[TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node status in unifocal, multifocal, and diffuse breast carcinomas: differences are related to macrometastatic disease.
Tot T
Ann Surg Oncol; 2012 Oct; 19(11):3395-401. PubMed ID: 22476758
[TBL] [Abstract][Full Text] [Related]
5. Diffuse invasive breast carcinoma of no special type.
Tot T
Virchows Arch; 2016 Feb; 468(2):199-206. PubMed ID: 26521062
[TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
7. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma.
Andea AA; Wallis T; Newman LA; Bouwman D; Dey J; Visscher DW
Cancer; 2002 Mar; 94(5):1383-90. PubMed ID: 11920492
[TBL] [Abstract][Full Text] [Related]
8. Early and more advanced unifocal and multifocal breast carcinomas and their molecular phenotypes.
Tot T
Clin Breast Cancer; 2011 Aug; 11(4):258-63. PubMed ID: 21729662
[TBL] [Abstract][Full Text] [Related]
9. Tumor Budding is a reliable predictor for death and metastasis in invasive ductal breast cancer and correlates with other prognostic clinicopathological parameters.
Okcu O; Öztürk Ç; Şen B; Arpa M; Bedir R
Ann Diagn Pathol; 2021 Oct; 54():151792. PubMed ID: 34293708
[TBL] [Abstract][Full Text] [Related]
10. Early (<10 mm) HER2-Positive Invasive Breast Carcinomas are Associated with Extensive Diffuse High-Grade DCIS: Implications for Preoperative Mapping, Extent of Surgical Intervention, and Disease-Free Survival.
Tot T
Ann Surg Oncol; 2015 Aug; 22(8):2532-9. PubMed ID: 25582746
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic analysis of microscopically invasive breast carcinoma.
Jimenez RE; Visscher DW
Hum Pathol; 1998 Dec; 29(12):1412-9. PubMed ID: 9865826
[TBL] [Abstract][Full Text] [Related]
12. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis.
Marinho VF; Metze K; Sanches FS; Rocha GF; Gobbi H
BMC Cancer; 2008 Feb; 8():64. PubMed ID: 18307818
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast.
Şener E; Şipal S; Gündoğdu C
Turk Patoloji Derg; 2016; 32(3):164-70. PubMed ID: 27562390
[TBL] [Abstract][Full Text] [Related]
14. Tumor budding in invasive breast cancer - An indispensable budding touchstone.
Kumarguru BN; Ramaswamy AS; Shaik S; Karri A; Srinivas VS; Prashant BM
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S117-S122. PubMed ID: 32108643
[TBL] [Abstract][Full Text] [Related]
15. [Node status in 454 ductal breast cancers cases according to the association with in situ component].
Carabias-Meseguer P; Cusidó-Gimferrer M; Zapardiel-Gutiérrez I; Tresserra-Casas F; Fábregas-Xauradó R; Xercavins-Montoya J
Ginecol Obstet Mex; 2011 Jan; 79(1):5-10. PubMed ID: 21966777
[TBL] [Abstract][Full Text] [Related]
16. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
[TBL] [Abstract][Full Text] [Related]
17. Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.
Jeschke U; Mylonas I; Kunert-Keil C; Dazert E; Shabani N; Werling M; Kuhn C; Janni W; Gerber B; Friese K
Oncol Rep; 2005 Mar; 13(3):413-9. PubMed ID: 15706409
[TBL] [Abstract][Full Text] [Related]
18. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast.
Gong Y; Sun X; Huo L; Wiley EL; Rao MS
Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of marginal adipose tissue invasion in ductal carcinoma of the breast.
Yamaguchi J; Ohtani H; Nakamura K; Shimokawa I; Kanematsu T
Am J Clin Pathol; 2008 Sep; 130(3):382-8. PubMed ID: 18701411
[TBL] [Abstract][Full Text] [Related]
20. Unifocal, multifocal and diffuse carcinomas: a reproducibility study of breast cancer distribution.
Cserni G; Bori R; Sejben I; Vörös A; Kaiser L; Hamar S; Csörgő E; Kulka J
Breast; 2013 Feb; 22(1):34-8. PubMed ID: 22698617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
